Evolent Health (EVH) Expected to Announce Earnings on Thursday

Evolent Health (NYSE:EVH) is expected to post its quarterly earnings results after the market closes on Thursday, February 20th. Analysts expect Evolent Health to post earnings of $0.38 per share and revenue of $651.01 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Evolent Health Stock Down 2.6 %

Shares of EVH opened at $9.60 on Thursday. The firm has a market capitalization of $1.12 billion, a price-to-earnings ratio of -10.55 and a beta of 1.45. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.04 and a current ratio of 1.04. The business’s fifty day moving average price is $10.91 and its two-hundred day moving average price is $19.43. Evolent Health has a 52 week low of $9.45 and a 52 week high of $35.00.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. BTIG Research decreased their price objective on Evolent Health from $36.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, December 3rd. Citigroup decreased their price objective on Evolent Health from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. JMP Securities decreased their price objective on Evolent Health from $27.00 to $18.00 and set a “market outperform” rating on the stock in a research report on Friday, January 10th. Oppenheimer cut their price target on Evolent Health from $28.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Finally, JPMorgan Chase & Co. cut their price target on Evolent Health from $15.00 to $13.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $18.38.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.